Literature DB >> 9444571

Ca2+/CaM-sensitive adenylyl cyclase activity is decreased in the Alzheimer's brain: possible relation to type I adenylyl cyclase.

M Yamamoto1, H Ozawa, T Saito, S Hatta, P Riederer, N Takahata.   

Abstract

Immunoreactivities of four subtypes of adenylyl cyclase (AC) (types I, II, IV and V/VI), and basal, forskolin- and Mn(2+)-stimulated AC activities with or without calcium and calmodulin (Ca2+/CaM) were estimated in parietal cortex membranes from cases with dementia of the Alzheimer type (DAT) and age-matched controls. Immunoreactivities of AC-I and AC-II were significantly decreased, but those of AC-IV and AC-V/VI did not change in DAT brains. There was a significant correlation of AC-I immunoreactivity with Ca2+/CaM-sensitive AC activity, but not with the Ca2+/CaM-insensitive activity. Ca2+/CaM-sensitive AC activity was significantly lower in DAT than in the control, indicating that impairment of Ca2+/CaM-sensitive AC-I is clearly involved in the pathophysiology of DAT.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444571     DOI: 10.1007/BF01291889

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  24 in total

1.  Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family.

Authors:  S Katsushika; L Chen; J Kawabe; R Nilakantan; N J Halnon; C J Homcy; Y Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 2.  Adenylate cyclase assay.

Authors:  Y Salomon
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

3.  Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure.

Authors:  J Krupinski; F Coussen; H A Bakalyar; W J Tang; P G Feinstein; K Orth; C Slaughter; R R Reed; A G Gilman
Journal:  Science       Date:  1989-06-30       Impact factor: 47.728

4.  Modification of the calcium and calmodulin sensitivity of the type I adenylyl cyclase by mutagenesis of its calmodulin binding domain.

Authors:  Z Wu; S T Wong; D R Storms
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

Review 5.  Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases.

Authors:  R Iyengar
Journal:  FASEB J       Date:  1993-06       Impact factor: 5.191

6.  Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila.

Authors:  J C Yin; J S Wallach; M Del Vecchio; E L Wilder; H Zhou; W G Quinn; T Tully
Journal:  Cell       Date:  1994-10-07       Impact factor: 41.582

7.  Synergistic activation of the type I adenylyl cyclase by Ca2+ and Gs-coupled receptors in vivo.

Authors:  G A Wayman; S Impey; Z Wu; W Kindsvogel; L Prichard; D R Storm
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

8.  Reduced immunoreactivity of adenylyl cyclase in dementia of the Alzheimer type.

Authors:  M Yamamoto; H Ozawa; T Saito; L Frölich; P Riederer; N Takahata
Journal:  Neuroreport       Date:  1996-11-25       Impact factor: 1.837

9.  Preservation of Gi-protein inhibited adenylyl cyclase activity in the brains of patients with Alzheimer's disease.

Authors:  R F Cowburn; C O'Neill; R Ravid; B Winblad; C J Fowler
Journal:  Neurosci Lett       Date:  1992-07-06       Impact factor: 3.046

10.  Developmentally expressed Ca(2+)-sensitive adenylyl cyclase activity is disrupted in the brains of type I adenylyl cyclase mutant mice.

Authors:  E C Villacres; Z Wu; W Hua; M D Nielsen; J J Watters; C Yan; J Beavo; D R Storm
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

View more
  10 in total

1.  Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice.

Authors:  Nancy Bartolotti; Laura Segura; Orly Lazarov
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 2.  Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.

Authors:  Michy P Kelly
Journal:  Cell Signal       Date:  2017-11-23       Impact factor: 4.315

3.  Complex noradrenergic dysfunction in Alzheimer's disease: Low norepinephrine input is not always to blame.

Authors:  Mary Gannon; Qin Wang
Journal:  Brain Res       Date:  2018-01-04       Impact factor: 3.252

Review 4.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 5.  Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.

Authors:  Elisa Zuccarello; Erica Acquarone; Elisa Calcagno; Elentina K Argyrousi; Shi-Xian Deng; Donald W Landry; Ottavio Arancio; Jole Fiorito
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

Review 6.  Capturing adenylyl cyclases as potential drug targets.

Authors:  Sandra Pierre; Thomas Eschenhagen; Gerd Geisslinger; Klaus Scholich
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

Review 7.  Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale.

Authors:  Owen Sanders; Lekshmy Rajagopal
Journal:  J Alzheimers Dis Rep       Date:  2020-06-16

8.  Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade.

Authors:  Erica Acquarone; Elentina K Argyrousi; Manon van den Berg; Walter Gulisano; Mauro Fà; Agnieszka Staniszewski; Elisa Calcagno; Elisa Zuccarello; Luciano D'Adamio; Shi-Xian Deng; Daniela Puzzo; Ottavio Arancio; Jole Fiorito
Journal:  Mol Neurodegener       Date:  2019-06-27       Impact factor: 14.195

9.  Absence of Ca2+-stimulated adenylyl cyclases leads to reduced synaptic plasticity and impaired experience-dependent fear memory.

Authors:  L Wieczorek; D Majumdar; T A Wills; L Hu; D G Winder; D J Webb; L J Muglia
Journal:  Transl Psychiatry       Date:  2012-05-29       Impact factor: 6.222

Review 10.  Global and local missions of cAMP signaling in neural plasticity, learning, and memory.

Authors:  Daewoo Lee
Journal:  Front Pharmacol       Date:  2015-08-04       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.